Enliven sticks to year-end ENABLE-2 start after FDA alignment on CML trial designNov 6Regulatory decisionEnliven TherapeuticsUpdated
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Sign inSign in